Viewing StudyNCT00008398

Bugs

eRecord

Ignite Creation Date: 2024-05-05 @ 11:20 AM

Last Modification Date: 2024-10-26 @ 9:06 AM

Study NCT ID: NCT00008398

Status: COMPLETED

Last Update Posted: 2013-11-19

First Post: 2001-01-06

Brief Title: Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Sponsor: Radiation Therapy Oncology Group

Organization: Radiation Therapy Oncology Group

Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions:

Keywords:

Name	View

radiation toxicity	View
stage I nasopharyngeal cancer	View
stage II nasopharyngeal cancer	View
stage III nasopharyngeal cancer	View
stage IV nasopharyngeal cancer	View
recurrent nasopharyngeal cancer	View
stage 0 paranasal sinus and nasal cavity cancer	View
stage 0 nasopharyngeal cancer	View
stage 0 oropharyngeal cancer	View
stage 0 laryngeal cancer	View
stage 0 hypopharyngeal cancer	View
untreated metastatic squamous neck cancer with occult primary	View
recurrent metastatic squamous neck cancer with occult primary	View
stage 0 lip and oral cavity cancer	View
stage I lip and oral cavity cancer	View
stage II lip and oral cavity cancer	View
stage III lip and oral cavity cancer	View
stage IV lip and oral cavity cancer	View
recurrent lip and oral cavity cancer	View
stage I hypopharyngeal cancer	View
stage II hypopharyngeal cancer	View
stage III hypopharyngeal cancer	View
stage IV hypopharyngeal cancer	View
recurrent hypopharyngeal cancer	View
stage I paranasal sinus and nasal cavity cancer	View
stage II paranasal sinus and nasal cavity cancer	View
stage III paranasal sinus and nasal cavity cancer	View
stage IV paranasal sinus and nasal cavity cancer	View
recurrent paranasal sinus and nasal cavity cancer	View
stage I oropharyngeal cancer	View
stage II oropharyngeal cancer	View
stage III oropharyngeal cancer	View
stage IV oropharyngeal cancer	View
recurrent oropharyngeal cancer	View
oral complications	View